Clicky

Accelerate Diagnostics Inc(1A8)

Description: Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.


Keywords: Medicine Infectious Diseases Antibiotics Infection Sepsis In Vitro Diagnostics Bacterial Disease Antimicrobial Resistance Bacteremia Antibiotic Sensitivity Serious Infections

Home Page: acceleratediagnostics.com

3950 South Country Club Road
Tucson, AZ 85714
United States
Phone: 520 365 3100


Officers

Name Title
Mr. Jack Phillips CEO, Pres & Director
Mr. Steve Reichling Chief Financial Officer
Mr. Ron Price Chief Commercial Officer of Americas
Dr. Lawrence Mertz Chief Technology Officer
Laura Pierson Investor Relations Officer
Mr. Michael Bridge Sr. VP, Gen. Counsel & Sec.
Ms. Gretchen Strohminger Sr. VP and Head of HR & Culture
Mr. Cherif Bousselham Sr. VP & Head of Sales - EMEA
Ms. Laura Costa Sr. VP & Head of Global Customer Support
Mr. John Meduri Chief Strategy Officer

Exchange: F

Country: DE

Currency: Euro (€)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0
Price-to-Sales TTM: 4.9686
IPO Date:
Fiscal Year End: December
Full Time Employees: 220
Back to stocks